ClinicalTrialsFinder

Primary Hyperoxaluria Type 1 Clinical Trials in Birmingham

1 recruitingBirmingham, United Kingdom

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)

Primary Hyperoxaluria Type 1 (PH1)
Arbor Biotechnologies23 enrolled7 locationsNCT06839235